Neuropathic Pain News and Research

RSS

Neuropathic pain is a type of pain that is caused by damage to the nervous system following an injury or illness and affects approximately 1% of the population.

Higher opioid doses do not seem to improve pain, study finds

Increasing chronic pain patients' opioid prescription doses does not seem to improve pain, according to a Veterans Affairs study.

5 Feb 2020

Scientists use human stem cells to make pain-killing neurons

Researchers at the University of Sydney have used human stem cells to make pain-killing neurons that provide lasting relief in mice, without side effects, in a single treatment.

23 Jan 2020

Media reports focus on treatments involving opioids and cannabis for chronic pain

New Zealand media reports on chronic pain are focusing on treatments involving opioids and cannabis at the expense of best practice non-drug treatments, researchers have found.

17 Jan 2020

Study: Understanding second-degree burns is key to treating these complications

New research shows how second-degree burns cause hard-to-treat chronic pain, and this understanding may be key to treating these complications, common in war veterans.

10 Jan 2020

Study provides new insights into experience of women with rare neurological disorder

Imagine living with unwanted sexual arousals, occurring unexpectedly and repeatedly, unrelated to any sexual desire or pleasure.

9 Jan 2020

SLU researcher honored for finding better pain treatments

Researcher Daniela Salvemini, Ph.D., professor of pharmacology and physiology at Saint Louis University, has been named a Fellow of the National Academy of Inventors for her contributions toward understanding and finding better treatments for pain.

23 Dec 2019

Evaluating safety and efficacy of migraine preventive treatment for children, adolescents

Cephalalgia, the official journal of the International Headache Society, published the article entitled "Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled trial", by Man Amanat, and Mahmoud Reza Ashrafi from the Tehran University of Medical Sciences, Tehran, Iran.

10 Dec 2019

Identifying the type of pain in adults with sickle cell disease may help improve treatment

Identifying the type of pain an adult with sickle cell disease experiences may be useful in improving treatment, according to a new study by researchers at Yale Cancer Center and Smilow Cancer Hospital.

8 Dec 2019

Common drug for nerve pain could help restore upper limb function after spinal cord injury

Long-term treatment with gabapentin, a commonly prescribed drug for nerve pain, could help restore upper limb function after a spinal cord injury, new research in mice suggests.

3 Dec 2019

Repeated infusions of ketamine for migraines or pain not linked to increased adverse events

Repeated infusions of ketamine treatments for migraines or pain was not associated with increased risk for hepatotoxicity or psychomimetic adverse drug events (ADEs), according to research from Thomas Jefferson University Hospital in Philadelphia, PA, and the University of Virginia at Charlottesville.

6 Nov 2019

Researchers successfully treat pain using nanoparticles to deliver a non-opioid medication

The use of nanoparticles to deliver a drug into specific nerve cells has resulted in significantly improved pain relief.

5 Nov 2019

Nanoparticle drug delivery enhances and prolongs pain relief in animal models

An international team of researchers has used nanoparticles to deliver a drug- one that previously failed in clinical trials for pain- into specific compartments of nerve cells, dramatically increasing its ability to treat pain in mice and rats.

4 Nov 2019

Temple researchers win NIH grant to study HIV-related neuroinflammation in context of opioid addiction

The National Institutes of Health has awarded a Temple research team a 5-year, $3.27 million grant to study neuroinflammation following HIV-infection in the context of opioid addiction.

16 Oct 2019

USF awarded $2.2 million to study neuromuscular effects of chemotherapy in breast cancer survivors

A University of South Florida College of Nursing researcher has been awarded a $2.2 million grant from the National Institutes of Health's National Cancer Institute to study whether a home-based exercise regimen to help improve gait and balance and strengthen muscles can lessen adverse neuromuscular effects many breast cancer survivors face after chemotherapy.

3 Oct 2019

Researchers create pain mediator profile for pancreatic diseases

In a recent study, a team at the Technical University of Munich (TUM) discovered the cause of this phenomenon for the first time: a particular neuroenzyme in the body is present in the nerves of the organ in high concentrations.

2 Oct 2019

UC Davis research team receives NIH grant to develop novel drugs for treating pain

A UC Davis research team, led by Vladimir Yarov-Yarovoy and Heike Wulff, will receive a $1.5 million grant from the National Institutes of Health to develop a novel class of peptides that are better at treating pain and don't have the side effects of opioids.

1 Oct 2019

Neuropathic Pain News and Research

Further Reading

Higher opioid doses do not seem to improve pain, study finds

Scientists use human stem cells to make pain-killing neurons

Media reports focus on treatments involving opioids and cannabis for chronic pain

Study: Understanding second-degree burns is key to treating these complications

Study provides new insights into experience of women with rare neurological disorder

SLU researcher honored for finding better pain treatments

Evaluating safety and efficacy of migraine preventive treatment for children, adolescents

Identifying the type of pain in adults with sickle cell disease may help improve treatment

Common drug for nerve pain could help restore upper limb function after spinal cord injury

Repeated infusions of ketamine for migraines or pain not linked to increased adverse events

Researchers successfully treat pain using nanoparticles to deliver a non-opioid medication

Nanoparticle drug delivery enhances and prolongs pain relief in animal models

Temple researchers win NIH grant to study HIV-related neuroinflammation in context of opioid addiction

USF awarded $2.2 million to study neuromuscular effects of chemotherapy in breast cancer survivors

Researchers create pain mediator profile for pancreatic diseases

UC Davis research team receives NIH grant to develop novel drugs for treating pain

In tiny doses, an addiction medication moonlights as treatment for chronic pain

Protein implicated in neuron growth and cell adhesion appears crucial for pain sensitization

SLU researchers receive $2.1 million to find non-addictive pain medications

Scientists discover new pain-sensing organ underneath the skin

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News